| | | | |

|
|
|  | Breast Imaging for the Pathologist |
|  | Clear Cells of Toker in the Nipple Epidermis |
|  | Core Biopsy of Non-Palpable Breast Lesions, Update |
|  | Familial Cancer Syndromes Involving the Breast |
|  | Progenitor Cell Concept, The |
|  | Surgical Pathology & FNA of the Breast and the Law |
|  | Topics in Breast Pathology - Then and Now |
|  | What the Surgeon Expects From the Pathologist |

|
|
|  | Atypical Ductal Hyperplasia, Papillary Lesions and |
|  | Atypical Ductal Hyperplasia, Update in Breast Disease: Oncotype Dx, E-cadherin, and High Molecular Weight Keratins in |
|  | Atypical Lobular Hyperplasia and Atypical Ductal Hyperplasia involving a Fibroadenoma |
|  | Atypical Lobular Hyperplasia and Focal Lobular Carcinoma In Situ |
|  | Atypical Lobular Hyperplasia involving Sclerosing Adenosis |
|  | Breast Lesions with Borderline Morphologic Features |
|  | Collision or Intimacy of LCIS and DCIS |
|  | Ductal and Lobular Neoplasia |
|  | Lobular Neoplasia (ALH and LCIS) |
|  | Pleomorphic Apocrine Lobular Carcinoma in Situ (PALCIS) |
|  | Pleomorphic Lobular Carcinoma In Situ and Carcinomas In Situ with Indeterminate Features |
|  | Preneoplastic Breast Disease and the Promise of Proteomic Analysis |
|  | Spindle Cell Neoplasms of the Breast:An Overview |

|
|
| General |
|  | Apocrine Lesions of the Breast |
|  | Atypical Pseudolactational Change and Cystic Hypersecretory Hyperplasia |
|  | Granulomatous Mastitis |
|  | Microglandular Adenosis |
|  | Mucinous Lesions of the Breast |
|  | Sclerosed Papilloma and Usual Hyperplasia Without Atypia |
|  | Spindle Cell Neoplasms of the Breast:An Overview |
|  Columnar Cell Lesions |
|  | Columnar Cell Lesions and Flat Epithelial Atypia |
|  | Columnar Cell Lesions and Flat Epithelial Atypia |
|  | Columnar Cell Lesions and Flat Epithelial Atypia of the Breast |
|  | Columnar Cell Lesions Of The Breast And Their Differential Diagnosis |
|  | Flat Epithelial Atypia (Atypical Lobular Hyperplasia) |

|
|
|  | Breast Lesion Diagnosis with FNA and Core Biopsy: Challenges and Opportunities |
|  | Consequences, Complications and Artifacts Following Core Needle Biopsy, Including Epithleial Displacement |
|  | Interpretation of Radiologic Guided Core Needle Biopsies, Diagnostic and Management Issues in the |

|
|
| General |
|  | Breast Cytology Specimens in the Evaluation of Prognostic and Predictive Markers and Markers of Increased Risk: Current Issues and Future Direction, Utility of |
|  | FNA versus Core Biopsy in Breast Diagnosis, Accuracy and Usefulness of |
|  Ductal Lavage |
|  | Cellular Atypia in the Quantitative Assessment of Breast Cancer Risk: Implications for Management, The Role of |
|  | Ductal Lavage and Ductoscopy: What Can We Learn From the Ductal Lining? |
|  | Ductal Lavage in Search of High Risk Breast Lesions: Distribution and Sampling Issues |
|  | Ductal Lavage: Morphology and Update on a Clinical Study in High Risk Patients |

|
|
|  | Fibroadenoma with Extensive Involvement by LCIS |
|  | Fibroepithelial And Stromal Lesions, Core Biopsy Of |
|  | Fibroepithelial Lesions of the Breast |
|  | Malignant Phyllodes Tumour |

|
|
|  | Collision or Intimacy of LCIS and DCIS |
|  | Ductal Carcinoma In Situ |
|  | Ductal Carcinoma in Situ: Morphology-Based Knowledge and Molecular Advances |

|
|
| General |
|  | Basal Like Breast Cancers |
|  | Biology-Driven Selection of Optimal Systemic Therapy for Primary Breast Cancer |
|  | Breast Cancer, The New and The Old |
|  | Cancer of the Breast in the Antiquity |
|  | High Risk Breast Lesions: Clinical Management - What a Medical Oncologist Needs from Pathology |
|  | Infiltrating Carcinoma of the Breast |
|  | Lobular Carcinoma in Situ (LCIS) (E-cadherin Negative) with Comedonecrosis, Present at the Inked Margin |
|  | Lobular Carcinoma in Situ: Past, Present and Future |
|  | Male Breast Cancer (MBC) |
|  | Metaplastic Carcinoma of the Breast |
|  | Microglandular Adenosis in Association with Invasive Ductal Carcinoma |
|  | Modern Classification of Breast Cancer-Should We Stick with Morphology or Convert to Molecular Profiles? |
|  | Pathologic Response Following Neoadjuvant Chemotherapy as an Outcome for Clinical and Translational Research |
|  | Substantial But Incomplete Pathologic Response to Neoadjuvant Chemotherapy with Residual Invasive Carcinoma in Breast and Lymph Nodes |
|  Hereditary Breast Cancer |
|  | Familial Susceptibility to Breast and GI Cancers: New Links |
|  | Hereditary Breast Cancer: Immunohistochemical Markers, Pathology of |
|  | Hereditary Breast Cancer:From Molecular Genetics to Pathology |
|  Management |
|  | Breast Cancer, Management of Women at Increased Risk for |
|  Prognostic Factors |
|  | Resistance to Endocrine Therapy of Breast Cancer: Mechanisms and Clinical Implications |
|  | Traditional Morphological Prognostic Factors (Short Course) |
|  Special Type Cancers |
|  | Adenoid Cystic Carcinoma of Breast, Solid/Basaloid Subtype |
|  | Epithelioid Angiosarcoma Arising in the Setting of Prior Radiation Therapy for Breast Cancer |
|  | Histiocytoid Invasive Lobular Carcinoma |
|  | In Situ and Invasive Lobular Carcinoma in Contemporary Breast Carcinoma Patients, Pertinent Issues Related to |
|  | Infiltrative Carcinoma, Atypical Medullary Type |
|  | Invasive Ductal Carcinoma Nst, Grade 3, Associated with Microglandular Adenosis with Atypia |
|  | Low Grade (Fibromatosis-Like) Spindle Cell Carcinoma of the Breast |
|  | Low Grade, Fibromatosis-like Metaplastic Carcinoma Arising in Association with a Complex Sclerosing Lesion |
|  | Low-Grade Adenosquamous Carcinoma (LGASC) |
|  | Metastatic Carcinoid Tumor |
|  | Monophasic Spindle Cell (Sarcomatous) Carcinoma |
|  | Neuroendocrine Carcinomas of the Breast |
|  | Solid Variant of Adenoid Cystic Carcinoma with Basaloid Features |
|  | Triple Negative and Basal-Like Breast Cancer: One or Many Diseases? Implications for Surgical Pathologists |
|  Staging |
|  | Breast Cancer, Problems in Pathologic Staging of |

|
|
|  | Breast Myxoma |
|  | Epithelioid Angiosarcoma of the Breast (s/p radiation therapy |
|  | Epithelioid Variant of Myofibroblastoma |
|  | Malignant Phyllodes Tumor |
|  | Multifocal Angiosarcoma Arising in Atypical Vascular Lesions of the Breast |
|  | Phyllodes Tumor of the Breast, Metaplastic Carcinoma Arising from a |
|  | Spindle Cell Neoplasms of the Breast:An Overview |
|  | Stromal Tumors, The Evolving Classification of |

|
|
| General |
|  | Breast Cancer: From Microarrays to Clinical Lab Testing, Molecular Classification of |
|  | Epigenetics of Breast Cancer |
|  | Gene Expression Profiling from Paraffin-embedded Samples |
|  | Genetic Alterations In Proliferative Breast Disease |
|  | Genetic Changes in Premalignant Breast Tissue |
|  | Her2/neu Analysis on FNA Smears and Core Biopsies of Primary and Metastatic Breast Cancer |
|  | Molecular Classification of ER Positive (Luminal) Cancers |
|  | Molecular Clonality Relationships in Initial Carcinomas, Ipsilateral Breast Failures, & Distant Metastases in Patients Treated with Breast-Conserving Therapy: Evidence Suggesting that Some Distant Metastases are Derived from Ipsilateral Breast Failures and that Metastases Can Metastasize |
|  | Molecular Markers for Targeted Therapy and Prediction of Prognosis in Breast Cancer |
|  | New Molecular Classifications of Breast. Is it Ready for Use in Daily Practice? |
|  | Quality, Patient Safety, and Error Reduction in Immunohistochemistry and FISH: Focus on ER/PR in Breast Cancer |
|  Her2 |
|  | HER-2/neu and Topoisomerse IIa Gene Amplification and Protein Expression in Invasive Breast Carcinomas: Chromogenic in-situ Hybridization and Immunohistochemical Analyses |
|  | HER2 Gene Amplification and Overexpression as a Target for Treatment of Breast Cancer Patients |
|  | HER2/neu Testing in Breast Cancer |

|
|
|  | Adenomyoepithelioma |
|  | Malignant Adenomyoepithelioma of Breast, Metastatic to the Lung and Kidney |
|  | Myoepithelial cells and Breast Cancer |
|  | Myoepithelial Lesions, Comparative Molecular Pathology of |

|
|
|  | Bilateral Metastatic Ovarian Papillary Serous Carcinoma |
|  | Lymphomas of the Breast |
|  | Metastatic Malignant Melanoma to the Breast |

|
|
|  | Non-Invasive Papillary Lesions of the Breast |
|  | Papillary Carcinoma In Situ (Complex sclerosing papillary lesion with associated DCIS) |
|  | Papillary Lesions of the Breast |
|  | Papillary Lesions of the Breast |

|
|
|  | Pathologic Observations and Their Significance |
|  | Sentinel Lymph Node Biopsy, Clinical Decision Making Based on Findings in |

|
|
|  | Breast Disease - Pitfalls (Short Course), Pre-operative Diagnosis of |
|  | Breast Pathology: Newly Recognized Lesions and Old Lesions Reevaluated |
|  | Diagnostic Problems in Breast Pathology - How to avoid the pitfalls, new entities and controversial lesions (Short Course) |

|
|
| General |
|  | Breast Tissue Samples: How to Optimize the Evaluation of Breast Tissue Samples - From Core Needle Biopsy to Margin Assessment |
|  | Non-Palpable Breast Lesions: How to Effectively Sample Non-Palpable Breast Lesions: Radiology/Pathology Correlation |
|  Core Biopsies |
|  | Core Biopsy of Non-Palpable Breast Lesions, Update |
|  | Core Biopsy Specimen Handling Microcalcifications & Pitfalls |
|  DCIS |
|  | DCIS Specimens, Pathology Work-up of |

|
|
| Immunohistochemistry |
|  | Breast Epithelial Proliferations, Role of Immunohistochemistry in Distinguishing Benign from Malignant |
|  | Hormone Receptor Analysis of Breast Cancer: Current Issues |
|  | IHC Determination of HER2/neu In Breast Cancer |
|  | Immunohistochemical Classification of Breast Cancer |
|  | Immunostains: Are Immunostains Useful Diagnostic Tools in Breast Pathology? |
|  | Major Diagnostic Problems in Breast Pathology Addressed by Immunohistochemistry |
|  | Predictive and Prognostic Immunohistochemical Markers in Breast Carcinoma |
|  | Uses and Limitations of Immunohistochemistry in Identyfing Stromal Invasion |
|  In-situ Hybridization |
|  | Chromogenic In Situ Hybridization in Diagnosis and Prognosis of Breast and Renal Cancers |